The role of FATP5 as a tumor suppressor in HCC (Hepatocellular carcinoma), both in vivo and in vitro, has been studied and provides a mechanistic link between disrupted lipid metabolism and redox homeostasis 33. This evidence concerns the gene SLC27A5 and hepatocellular carcinoma.